# DOMPE -MT Neurotrophic Keratitis

> **NCT06947850** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Toyos Clinic** · enrollment: 10 (estimated)

## Conditions studied

- Dry Eye
- Neurotrophic Keratitis

## Interventions

- **DRUG:** Cenegermin Ophthalmic Solution [Oxervate]

## Key facts

- **NCT ID:** NCT06947850
- **Lead sponsor:** Toyos Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-21
- **Primary completion:** 2025-09-25
- **Final completion:** 2025-09-25
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06947850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06947850, "DOMPE -MT Neurotrophic Keratitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06947850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*